At MiMARK we envision the gynecological fluid as the next step in liquid matrix biopsy in gynecology. We are developing new In Vitro Diagnostic products for improving women’s health based on our deep understanding of gynecological fluids. We aim to leverage knowledge and understanding of gynecological conditions that will help address critical issues affecting women’s healthcare; underdiagnosis or misdiagnosis of malignancies, physical and mental invasiveness of gynecological testing, and disbelief and undertreatment of women’s pain. WomEC, our first innovation, will revolutionize the current diagnostic pathway of Endometrial Cancer, by providing an advanced immunoassay for minimally invasive, fast, and precise diagnosis.